Stimulated saliva secretion is reduced in proton pump inhibitor-resistant severe reflux esophagitis patients
- 15 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Esophagus
- Vol. 18 (3), 676-683
- https://doi.org/10.1007/s10388-021-00825-1
Abstract
Background Salivary secretion in patients with proton-pump inhibitor (PPI)-resistant severe reflux esophagitis has not been examined. In this study, saliva secretion and salivary epidermal growth factor (EGF) in patients with PPI-resistant severe reflux esophagitis were investigated. Methods We recruited 22 PPI-resistant and 22 PPI-responsive severe reflux esophagitis patients who were not infected with Helicobacter pylori. Saliva secretion testing and esophageal manometry using high-resolution manometry were performed. Saliva secretion was assessed as follows: each patient chewed sugar-free gum for 3 min prior to endoscopy and the amount and pH of saliva as well as the pH of saliva after acid loading as an index of the acid-buffering capacity were measured. The salivary EGF concentration was assessed by ELISA. Results The amount of saliva secreted was significantly lower in the PPI-resistant group than in the PPI-responsive group, with medians (25th-75th percentile) of 3.7 (2.2–6.8) and 4.9 (4.0–7.8) mL, respectively (p = 0.029). Salivary pH was significantly lower in the PPI-resistant group [6.9 (6.7–7.2)] than in the PPI-responsive group [7.2 (7.1–7.4), p = 0.001]. Salivary pH after acid loading was significantly lower in the PPI-resistant group [5.6 (5.3–5.9)] than in the PPI-responsive group [6.4 (6.1–6.5), p = 0.002]. The salivary EGF concentration was significantly higher in the PPI-resistant group [3211.5 (1865.0–4121.5)] than in the PPI-responsive group [1816.0 (1123.5–2792.3), p = 0.041]. No significant differences were observed in the proportion of esophageal motility abnormalities. Conclusion Stimulated saliva secretion was reduced in PPI-resistant severe reflux esophagitis patients.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP20K082973)
This publication has 43 references indexed in Scilit:
- Investigation of pretreatment prediction of proton pump inhibitor (PPI)-resistant patients with gastroesophageal reflux disease and the dose escalation challenge of PPIs—TORNADO study: a multicenter prospective study by the Acid-Related Symptom Research Group in JapanThe Esophagus, 2011
- The modified glucose clearance test: a novel non-invasive method for differentiating non-erosive reflux disease and erosive oesophagitisAlimentary Pharmacology & Therapeutics, 2008
- Therapeutic effects of 10 mg/day rabeprazole administration on reflux esophagitis was not influenced by the CYP2C19 polymorphismJournal of Gastroenterology and Hepatology, 2006
- Effect of topical esophageal acidification on salivary secretion: Identification of the mechanism of actionJournal of Gastroenterology and Hepatology, 2005
- Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classificationGut, 1999
- Role of salivary and seric epidermal growth factor in pathogenesis of reflux esophagitis in chronic alcoholics and nondrinkersDigestive Diseases and Sciences, 1996
- Enhancement of Wound Healing by Topical Treatment with Epidermal Growth FactorNew England Journal of Medicine, 1989
- The salivary flow rate and composition of whole and parotid resting and stimulated saliva in young and old healthy subjectsBiochemical Medicine and Metabolic Biology, 1986
- Age-related Salivary Flow Rate Changes in Controls and Patients with Oral Lichen PlanusJournal of Dental Research, 1985
- Effect of Esophageal Emptying and Saliva on Clearance of Acid from the EsophagusNew England Journal of Medicine, 1984